Because of its protective role against chronic inflammation, insulin resistance, weight gain, obesity and cardiovascular disease, adiponectin is evaluated as an important potential target for therapy development [48]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.